Moreover, overexpression of HOXA9 is observed in many non-MLL fusion-mediated leukemias such as those with NPM1 mutation and NUP98 fusion and is associated with poor prognosis (Collins and Hess, 2016). The gene discussed is KMT2A; the disease is leukemia.